Pacific Biosciences of California, Inc. (PACB)

PACB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	616	539	2,624	1,850	4,513	4,833
Market Cap Growth	16.51%	-79.47%	41.85%	-59.02%	-6.61%	514.40%
Enterprise Value	1,020	988	2,792	1,964	4,387	4,667
Last Close Price	2.04	1.83	9.81	8.18	20.46	25.94
PE Ratio	-	-	-	-	-	164.37
PS Ratio	3.90	3.50	13.08	14.42	34.58	61.26
PB Ratio	17.06	1.06	3.74	3.29	5.71	14.41
P/TBV Ratio	-	-	-	-	-	14.41
P/FCF Ratio	-	-	-	-	-	261.74
P/OCF Ratio	-	-	-	-	-	247.80
EV/Sales Ratio	6.60	6.42	13.93	15.30	33.61	59.16
EV/FCF Ratio	-	-	-	-	-	252.78
Debt / Equity Ratio	19.48	1.33	1.33	1.69	1.21	0.13
Debt / FCF Ratio	-	-	-	-	-	2.28
Asset Turnover	0.14	0.10	0.11	0.07	0.11	0.28
Inventory Turnover	1.62	1.84	2.66	2.00	3.68	3.36
Quick Ratio	5.21	6.30	7.03	3.00	14.90	8.72
Current Ratio	6.24	7.48	7.81	3.24	15.36	9.24
Return on Equity (ROE)	-205.90%	-51.30%	-48.53%	-46.42%	-32.17%	15.06%
Return on Assets (ROA)	-32.23%	-12.08%	-11.04%	-10.10%	-9.20%	-23.22%
Return on Capital (ROIC)	-34.37%	-12.91%	-12.33%	-11.70%	-10.49%	-26.41%
Return on Capital Employed (ROCE)	-78.50%	-24.30%	-18.80%	-20.30%	-9.20%	-27.80%
Earnings Yield	-81.77%	-57.53%	-11.69%	-16.99%	-4.01%	0.61%
FCF Yield	-20.50%	-39.41%	-10.21%	-15.14%	-2.60%	0.38%
Buyback Yield / Dilution	-9.13%	-8.22%	-12.95%	-10.00%	-16.67%	-14.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q